Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi badbat
Great potential
This is Future of surgery
May be a funding issue lots of ways to fund tho have to wait n see with that one
Arms medical and 2swell are probably working wth them And they are hard core business people
They will assist them to drive their products globally I
I believe this will easily double plus but patience is required
Global company that products are in great demand For the cost of 1.50 ish it’s a no brainier
Watching: ShearClass is Optimist this is a def, same style of rubbish. By the way what do you recon with this share?
Shearclass
Is just another deramper he never has a positive word to say on any of BBs
Just ignore him lol
Hi Shearclass, I posted this for you last week but you failed to respond, so I'll try again.
Through our understanding and re-reading all the current RNS's the consensus is that MidCap will allow TRX to have the repaid £5m end Feb or March once TRX have used their own cash in the bank. The part about recapitalization can be interpreted in few ways but nobody on this board is expecting there to be a cash call except where MidCap back out of their agreement.
All growing companys need finance and Midcap are not the only lenders available especially if manufacturing has increased last quarter as predicted.
Chester.
Nice blue start !
Just bought a few to square my holding up 185193 makes the gain easier to calculate
now waiting for the news as has been suggested .
GLA
Chesters valuation of our assets make the case pretty clear for investing at these levels.
Its not the word funding..its the word placing thats scares investors...apparently their are those that cannot tell the difference.
Don’t all growing businesses need funding? Why is this scary to investors?
The reality is... many ways to get cash when a company has good prospects, IP, high demand, etc.
Quite exactly what we have here ;-)
Great ramping, the reality is they need cash...
“The Company's cash balance as at 31 October 2019 was $9.3 million including $0.6 million of drawn RCF. Following the Repayment, the Company will have cash of approximately $3.7 million including $0.7 million of the drawn revolver and as at 31 October 2019 the business had access to a further $1.1 million of the RCF based on the available inventory and receivables at that time.
The Company estimates that, following the Repayment, it currently has sufficient working capital until at least the end of March 2020. The Board is currently considering the funding requirements, and further announcements will be made at the appropriate time.“
Dev. I got my holding with cash in reserve. If good news comes I will pounce on it. I got a suspicion we are going to have quite a lot of good news in the future.
All the best.
Good point Woodstock . I am also having a battle with myself along the same lines
my head or my gut?
Guess thats a given then Ill be loading up in the morning !
I am tempted to go over my comfort level with Trx. I have to stick to my rules. I hate being sensible. Stocks can go down as well as up.
Grrrr.
I agree this is worth holding for five years. I hope we do not have a takeover. The company is making a name for itself.
On that note. Good week all.
I wonder if any competitor is sliding the rule over TRX or is it to far to think that TRX are looking for a merger either way with the sales forecast I am sure they will be able to get corporate funding
chester
I hear what you say, but currently can find no other investment which is as compelling as this.
As we are just above the lowest sp value ever, the only conclusion I can make is that sp must rise as TR1's may be published soon, confirming the seller is done.
That said, you are 100% correct.
I do not now how to value a license agreement, but I hope to hear of some soon!
Thanks, I just wanted to make sure that the focus is not all about the need for capital.
As I keep saying all growing company's need cash as they build their businesses. There is absolutely nothing wrong with that as long as the underlying trend is growth and greater potential profits.
Once TRX cross the £40million pa turnover (probably 2022) figure they will be creating plenty of cash. The exciting thing is that they can continue building the business into the hundreds of millions and the share price will be many many multiples of that 6p I mentioned earlier.
Buy the stock, try and tell yourself that this is a five year bond and put it away.
There is a very good chance that your investment could mature into a very worthwhile pot of gold.
Last word, only invest what you can afford to lose because nothing is guaranteed.
Chester.
chester
Good attempt to put a value against products and IP.
I think you have E) undervalued though.
We payed 30.0M USD for Cellright, but as they're output is considerably higher now because customer base
now includes Arthrex, I'd say $50M (£38M).
If your going to top up consider doing it sooner rather than later.
I'm all in.
Good post Chester,
sort of puts things into perspective . And thats why i am waiting eagerly for the first licence agreement to arrive...validates the ip.
At the moment we appear to have products better than whats currently available...a licensing agreement with a couple of the big pharmaceuticals not only confirms this it accelerates the pathway to profit.
Tells the market what we have is better than the rest...2020 will hopefully see this confirmed..imo. i say hopefully because these agreements can take ages to come to fruition ..the licencee will want an instant roi and get all the production, distribution deals sorted before signing.
Couldn’t agree more Chester, 6p is very achievable I’m looking forward to the next couple of months it’s gonna be interesting that’s more sure!
Here's a question that will help focus your attention on why 1.5p a share is the bargain of a lifetime.
Let's presume there is a fire sale:
What would the various parts of TRX go for?
A) DemaPure, an FDA approved, clinically proven to be safe, cost effective and clinically desired regenerative tissue product.
What is the value of IP, the Patents, the processing plant processing IP and the current growing customer base.
What shall we put £20M, £30M? It's got to be up there in the tens of millions.
B) The heart valve replacement, GMB V joint venture in Germany / Europe. £2M min.
C) SurgiPure XD, FDA approved, proven to be safe just as DermaPure and again all the IP, Patents and customer base. £10M / £15M
D) OrthoPure XT once approved £10m min.
E) Then add all the CellRight BioRinse tech, IP, Patents and signed up contacts. TRX paid £26M in 2017 so let's just say that three years later it's still only worth what was paid.
So even if the rug was pulled from under us the piece parts of the TRX group has to be in excess of £70 / £80Million.
In other words 6p a share, so any and I mean any, good news about production, current level of sales, new contracts, new finance agreement means that 6p has to be the first re-rate position.
This is why the share is a tremendous opportunity and investment.
All my own opinion but I've tried to keep the values sensible. Any comments and other opinions are most welcome.
Chester.